© 2026 Optics and Photonics at Nottingham
43%
56.3%
8.8%
£5m+
Data for 2020-2025 from SciVal
Subhani, Mohsan; Sheth, Abhishek; Palaniyappan, Naaventhan; Sugathan, Peuish; Wilkes, Emilie A; Aithal, Guruprasad P
Diagnostic accuracy of serum ascites albumin gradient (SAAG) in a contemporary unselected medical cohort Journal Article
In: J. Int. Med. Res., vol. 50, no. 11, pp. 3000605221140310, 2022.
Abstract | Tags: ascites, cirrhosis, contemporary cohort, cytology, liver disease, retrospective, serum ascites albumin gradient
@article{Subhani2022-er,
title = {Diagnostic accuracy of serum ascites albumin gradient (SAAG)
in a contemporary unselected medical cohort},
author = {Mohsan Subhani and Abhishek Sheth and Naaventhan Palaniyappan and Peuish Sugathan and Emilie A Wilkes and Guruprasad P Aithal},
year = {2022},
date = {2022-11-01},
journal = {J. Int. Med. Res.},
volume = {50},
number = {11},
pages = {3000605221140310},
publisher = {SAGE Publications},
abstract = {OBJECTIVES: To describe the different aetiologies of ascites and
test the validity of serum ascites albumin gradient (SAAG) and
cytology in a contemporary unselected medical cohort. METHODS:
All adult patients admitted to Nottingham University Hospitals,
UK, between 1 May 2013 and 30 April 2018 with new-onset
radiologically-confirmed ascites were included. Data were
analysed to determine the distribution of different aetiologies
of ascites and the diagnostic accuracy of SAAG in portal
hypertension and cytology in malignancy as underlying causes of
ascites. RESULTS: Over 5 years, 286 patients presented with
new-onset ascites; 122 surgical cases were excluded. Most patients were men (n = 84, 51.2%) over 50 years of age (n = 142, 86.6%). Cirrhosis accounted for 54.9% (n = 90) of the cases of ascites followed by malignancy (n = 48, 29.3%) and cardiac failure (n = 10, 6.1%). SAAG $geq$11 g/L had a
sensitivity of 85.5% and specificity of 60.6% for diagnosing portal hypertension as a cause of ascites (diagnostic accuracy =
78.5%, 95% confidence interval (CI): 69.8-85.5; area under the curve (AUC) = 0.756, 95% CI: 0.652-0.860). Ascitic fluid
cytology was positive in 50% of malignant cases and 66% of
primary peritoneal carcinomatosis cases. CONCLUSION: The
underlying aetiology and the validity of available tests varied
substantially compared with previous reports.},
keywords = {ascites, cirrhosis, contemporary cohort, cytology, liver disease, retrospective, serum ascites albumin gradient},
pubstate = {published},
tppubtype = {article}
}
Macken, Lucia; Palaniyappan, Naaventhan; Verma, Sumita; Aithal, Guruprasad
Large volume paracentesis: to do or where to do? Journal Article
In: Gut, vol. 70, no. 12, pp. 2401–2402, 2021.
@article{Macken2021-pd,
title = {Large volume paracentesis: to do or where to do?},
author = {Lucia Macken and Naaventhan Palaniyappan and Sumita Verma and Guruprasad Aithal},
year = {2021},
date = {2021-12-01},
journal = {Gut},
volume = {70},
number = {12},
pages = {2401\textendash2402},
publisher = {BMJ},
keywords = {ascites, cirrhosis},
pubstate = {published},
tppubtype = {article}
}
Aithal, Guruprasad P; Palaniyappan, Naaventhan; China, Louise; Härmälä, Suvi; Macken, Lucia; Ryan, Jennifer M; Wilkes, Emilie A; Moore, Kevin; Leithead, Joanna A; Hayes, Peter C; O'Brien, Alastair J; Verma, Sumita
Guidelines on the management of ascites in cirrhosis Journal Article
In: Gut, vol. 70, no. 1, pp. 9–29, 2021.
Abstract | Tags: ascites, cirrhosis
@article{Aithal2021-ns,
title = {Guidelines on the management of ascites in cirrhosis},
author = {Guruprasad P Aithal and Naaventhan Palaniyappan and Louise China and Suvi H\"{a}rm\"{a}l\"{a} and Lucia Macken and Jennifer M Ryan and Emilie A Wilkes and Kevin Moore and Joanna A Leithead and Peter C Hayes and Alastair J O'Brien and Sumita Verma},
year = {2021},
date = {2021-01-01},
journal = {Gut},
volume = {70},
number = {1},
pages = {9\textendash29},
publisher = {BMJ},
abstract = {The British Society of Gastroenterology in collaboration with
British Association for the Study of the Liver has prepared this
document. The aim of this guideline is to review and summarise
the evidence that guides clinical diagnosis and management of
ascites in patients with cirrhosis. Substantial advances have
been made in this area since the publication of the last
guideline in 2007. These guidelines are based on a comprehensive
literature search and comprise systematic reviews in the key
areas, including the diagnostic tests, diuretic use, therapeutic
paracentesis, use of albumin, transjugular intrahepatic
portosystemic stent shunt, spontaneous bacterial peritonitis and
beta-blockers in patients with ascites. Where recent systematic
reviews and meta-analysis are available, these have been updated
with additional studies. In addition, the results of prospective
and retrospective studies, evidence obtained from expert
committee reports and, in some instances, reports from case
series have been included. Where possible, judgement has been
made on the quality of information used to generate the
guidelines and the specific recommendations have been made
according to the 'Grading of Recommendations Assessment,
Development and Evaluation (GRADE)' system. These guidelines are
intended to inform practising clinicians, and it is expected
that these guidelines will be revised in 3 years' time.},
keywords = {ascites, cirrhosis},
pubstate = {published},
tppubtype = {article}
}
A part of the University of Nottingham
© 2026 Optics and Photonics at Nottingham. Created for free using WordPress and Kubio